References of "CAVALIER, Etienne"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailLes anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic
Cavalier, Etienne ULg; Delanaye, Pierre ULg; Beckers, Albert ULg

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 220 (5 ULg)
Full Text
Peer Reviewed
See detailDétection précoce de l'hyperparathyroïdie secondaire : impact de l'établissement des valeurs de références de la parathormone
Cavalier, Etienne ULg; Delanaye, Pierre ULg; Beckers, Albert ULg

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 32 (3 ULg)
Full Text
Peer Reviewed
See detailLes anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic
Cavalier, Etienne ULg; Carlisi, A.; Delanaye, Pierre ULg et al

in Annales d'Endocrinologie (2010, September), 71(5), 367-68

Detailed reference viewed: 15 (0 ULg)
See detailHigh Kisspeptine-10 levels in obese hypogonadic patients : is kisspeptine-10 a periheral signal between metabolism and reproduction
Valdes Socin, Hernan Gonzalo ULg; Cavalier, Etienne ULg; Beckaert, A. C. et al

in European Neuroendocrine Association - Liège, 22-25 septembre 2010 (2010, September)

Detailed reference viewed: 35 (8 ULg)
Full Text
Peer Reviewed
See detailThe Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma.
Cavalier, Etienne ULg; Daly, Adrian ULg; Betea, Daniela ULg et al

in Journal of Clinical Endocrinology and Metabolism (2010), 95

Background: Parathyroid carcinoma (PCa) is a rare disease that can be difficult to differentiate initially from severe benign parathyroid adenoma. PCa oversecrete the amino form of PTH, which is ... [more ▼]

Background: Parathyroid carcinoma (PCa) is a rare disease that can be difficult to differentiate initially from severe benign parathyroid adenoma. PCa oversecrete the amino form of PTH, which is recognized by third-generation but not by second-generation PTH immunoassays. In normal individuals, the third-generation to second-generation PTH ratio should be less than 1. Objective: Our objective was to study the utility of the third-generation to second-generation PTH ratio as a means of distinguishing PCa patients (n = 24) from control groups with and without disorders of calcium secretion, including patients on renal hemodialysis (n = 74), postrenal transplantation (n = 60), and primary hyperparathyroidism (PHP; n = 30). Setting and Design: We conducted a retrospective, laboratory-based study at tertiary referral academic centers. Results: The mean third-generation to second-generation ratio was 0.58 ± 0.10 in the dialysis patients, 0.54 ± 0.10 in the renal transplant group, 0.54 ± 0.12 in the elderly healthy patients, and 0.68 ± 0.11 in the PHP group. All 245 of these patients presented a PTH third-generation to second-generation ratio of less than 1. In contrast, we observed an inverted third-generation to second-generation PTH ratio of more than one in 20 PCa patients, whereas only four PCa patients had a normal ratio of less than 1. Conclusions: An inverted third-generation to second-generation PTH ratio occurred in the majority of patients with advanced PCa and was absent in all 245 relevant controls. A third-generation to second-generation PTH ratio higher than 1 had a sensitivity of 83.3% and a specificity of 100% among PHP patients as a marker for PCa. This ratio may be useful to identify patients with PCa earlier and to detect patients either at risk of developing PCa or those in whom recurrence is taking place. [less ▲]

Detailed reference viewed: 57 (9 ULg)
See detailVitamin D symposium
CAVALIER, Etienne ULg

Conference (2010, June 04)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailValidation of the ImmunoCAP ISAC
Gadisseur, Romy ULg; Blanco Catafal, Anna; Chapelle, Jean-Paul ULg et al

in Clinical Chemistry (2010, June), 56(S6), 97

Detailed reference viewed: 83 (5 ULg)
Full Text
Peer Reviewed
See detailEvaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination
Cavalier, Etienne ULg; Carlisi, Ignazia ULg; Bekaert, Anne-Catherine ULg et al

in Clinical Chemistry (2010, June), 56(S6), 188

Detailed reference viewed: 40 (2 ULg)
Full Text
Peer Reviewed
See detailAnalytical validation of the Abbott Architect urine NGAL
Cavalier, Etienne ULg; Saarbach, D.; Bekaert, Anne-Catherine ULg et al

in Clinical Chemistry (2010, June), 56(S6), 96

Detailed reference viewed: 77 (2 ULg)
Full Text
See detailPlace du dosage de la vitamine D
Cavalier, Etienne ULg

Conference (2010, April 03)

Detailed reference viewed: 28 (1 ULg)
Full Text
Peer Reviewed
See detailEffects of large pore hemofiltration in a swine model of fulminant hepatic failure
Detry, Olivier ULg; Janssen, Nathalie ULg; Cheramy-Bien, Jean-Paul ULg et al

in Acta Chirurgica Belgica (2010, April), 110

Detailed reference viewed: 12 (2 ULg)
Full Text
Peer Reviewed
See detailConsequences of laparoscopy on liver ischemia during portal triad clamping in a swine model
Nsadi, Berthier; Pire, E.; Gilson, Nathalie ULg et al

in Acta Chirurgica Belgica (2010, April), 110

Detailed reference viewed: 36 (7 ULg)
See detailFirst experience with Architect urine NGAL
Cavalier, Etienne ULg; Delanaye, Pierre ULg

Conference (2010, March 25)

Detailed reference viewed: 33 (2 ULg)
See detailVitamin D and atherosclerosis
Cavalier, Etienne ULg

Conference (2010, March 09)

Detailed reference viewed: 18 (0 ULg)
Full Text
Peer Reviewed
See detailMethods for Vitamin D measurement - analytical problems and clinical relevance
Cavalier, Etienne ULg

Conference (2010, March 05)

Detailed reference viewed: 53 (2 ULg)
Full Text
See detailLaboratoire et allergologie : nouvelles applications
Gadisseur, Romy ULg; Cavalier, Etienne ULg

Conference (2010, March 02)

Detailed reference viewed: 20 (3 ULg)